Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/34352
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSalama, SA-
dc.contributor.authorDE BONDT, Mirre-
dc.contributor.authorBerghmans, N-
dc.contributor.authorGOUWY, Mieke-
dc.contributor.authorde Oliveira, VLS-
dc.contributor.authorOliveira, SC-
dc.contributor.authorAmaral, FA-
dc.contributor.authorProost, P.-
dc.contributor.authorVan Damme, J-
dc.contributor.authorStruyf, S-
dc.contributor.authorDe Buck, M-
dc.date.accessioned2021-06-25T10:19:18Z-
dc.date.available2021-06-25T10:19:18Z-
dc.date.issued2020-
dc.date.submitted2021-06-18T06:47:17Z-
dc.identifier.citationMEDIATORS OF INFLAMMATION, (Art N° 6087109)-
dc.identifier.urihttp://hdl.handle.net/1942/34352-
dc.description.abstractThe serum amyloid A (SAA) gene family is highly conserved and encodes acute phase proteins that are upregulated in response to inflammatory triggers. Over the years, a considerable amount of literature has been published attributing a wide range of biological effects to SAAs such as leukocyte recruitment, cytokine and chemokine expression and induction of matrix metalloproteinases. Furthermore, SAAs have also been linked to protumorigenic, proatherogenic and anti-inflammatory effects. Here, we investigated the biological effects conveyed by murine SAA3 (mu rSAA3) recombinantly expressed inEscherichia coli. We observed the upregulation of a number of chemokines including CCL2, CCL3, CXCL1, CXCL2, CXCL6 or CXCL8 following stimulation of monocytic, fibroblastoid and peritoneal cells with mu rSAA3. Furthermore, this SAA variant displayed potentin vivorecruitment of neutrophils through the activation of TLR4. However, a major problem associated with proteins derived from recombinant expression in bacteria is potential contamination with various bacterial products, such as lipopolysaccharide, lipoproteins and formylated peptides. This is of particular relevance in the case of SAA as there currently exists a discrepancy in biological activity between SAA derived from recombinant expression and that of an endogenous source, i.e. inflammatory plasma. Therefore, we subjected commercial recombinant mu rSAA3 to purification to homogeneity via reversed-phase high-performance liquid chromatography (RP-HPLC) and re-assessed its biological potential. RP-HPLC-purified mu rSAA3 did not induce chemokines and lackedin vivoneutrophil chemotactic activity, but retained the capacity to synergize with CXCL8 in the activation of neutrophils. In conclusion, experimental results obtained when using proteins recombinantly expressed in bacteria should always be interpreted with care.-
dc.language.isoen-
dc.publisherHINDAWI LTD-
dc.rightsCopyright © 2020 Sara Abouelasrar Salama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.-
dc.titleBiological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case-
dc.typeJournal Contribution-
local.bibliographicCitation.jcatA1-
local.publisher.placeADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.bibliographicCitation.artnr6087109-
dc.identifier.doi10.1155/2020/6087109-
dc.identifier.isiWOS:000553448500001-
local.provider.typeWeb of Science-
local.uhasselt.uhpubyes-
local.uhasselt.internationalyes-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
item.contributorSalama, SA-
item.contributorDE BONDT, Mirre-
item.contributorBerghmans, N-
item.contributorGOUWY, Mieke-
item.contributorde Oliveira, VLS-
item.contributorOliveira, SC-
item.contributorAmaral, FA-
item.contributorProost, P.-
item.contributorVan Damme, J-
item.contributorStruyf, S-
item.contributorDe Buck, M-
item.fullcitationSalama, SA; DE BONDT, Mirre; Berghmans, N; GOUWY, Mieke; de Oliveira, VLS; Oliveira, SC; Amaral, FA; Proost, P.; Van Damme, J; Struyf, S & De Buck, M (2020) Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case. In: MEDIATORS OF INFLAMMATION, (Art N° 6087109).-
crisitem.journal.issn0962-9351-
crisitem.journal.eissn1466-1861-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
6087109.pdfPublished version1.84 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.